Viewing Study NCT05709912



Ignite Creation Date: 2024-05-06 @ 6:33 PM
Last Modification Date: 2024-10-26 @ 2:50 PM
Study NCT ID: NCT05709912
Status: RECRUITING
Last Update Posted: 2023-10-03
First Post: 2023-01-24

Brief Title: Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Study Overview

Official Title: Randomized Controlled Trial of a Psychosocial Mobile Application App to Promote Coping for Caregivers of Patients Receiving Hematopoietic Cell Transplantation HCT
Status: RECRUITING
Status Verified Date: 2023-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this research study is to determine whether a self-administered psychosocial mobile application CARE app is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation HCT
Detailed Description: This is a randomized clinical trial to determine whether a psychosocial mobile application CARE app is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation HCT The CARE app was developed with the goal of addressing the needs of caregivers of HCT recipients

Participants will be randomized into one of two study groups CARE app plus Usual Care versus Usual Care

Participation in this study is expected to last up to 100 days after HCT

It is expected that about 120 people will take part in this research study

The Leukemia and Lymphoma Society is supporting this research by providing funding

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None